Conmed (CNMD) Free Cash Flow (2010 - 2026)

Conmed has reported Free Cash Flow for 17 years, with the latest figure at $10.6 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 71.98% year-over-year to $10.6 million; the trailing twelve-month figure through Mar 2026 stood at $123.7 million (down 24.82% YoY), and the FY2025 full-year result was $150.9 million, down 1.95% from the prior year.
• Free Cash Flow for Q1 2026 stood at $10.6 million, down from $41.2 million in the prior quarter.
• The five-year high for Free Cash Flow was $51.5 million in Q4 2023, with the low at -$17.3 million in Q4 2022.
• Historically, Free Cash Flow has averaged $25.5 million across 5 years, with a median of $27.1 million in 2024.
• Annual changes were most pronounced in 2022 — Free Cash Flow slumped 156.46% — and 2024, when it soared 434.35%.
• Conmed's Free Cash Flow stood at -$17.3 million in 2022, then jumped by 398.37% to $51.5 million in 2023, then decreased by 23.75% to $39.3 million in 2024, then increased by 4.9% to $41.2 million in 2025, then slumped by 74.34% to $10.6 million in 2026.
• The last three Free Cash Flow figures came in at $10.6 million (Q1 2026), $41.2 million (Q4 2025), and $48.5 million (Q3 2025), per Business Quant data.